Obesity
Also known as: Adiposity-Based Chronic Disease · ABCD · Excess Adiposity
Obesity is a chronic, relapsing condition of excess adiposity associated with metabolic, cardiovascular, hormonal, and musculoskeletal sequelae. It is treated as a physiologic disease — not a willpower deficit — and responds to medical, behavioral, and surgical pathways.
What you need to know
Modern endocrinology frames obesity as adiposity-based chronic disease (ABCD): a relapsing physiological state with neurohormonal drivers (leptin resistance, GLP-1 signaling, insulin resistance) rather than a behavioral failure. Body composition matters more than scale weight — visceral adiposity, lean mass, and metabolic biomarkers (A1C, fasting insulin, lipids, ApoB) define the underlying physiology. Provider-reviewed pathways include GLP-1 receptor agonist optimization (semaglutide, tirzepatide) paired with resistance training and biomarker recalibration to preserve lean mass.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Diagnostic biomarkers
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.